Life Sciences KidneyIntelX Receives New York State Approval to Commence Commercial Testing AIT News Desk Jun 16, 2020 Renalytix AI plc, an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to…
Life Sciences Renalytix AI Announces Proposed Dual-listing on Nasdaq AIT News Desk May 19, 2020 Renalytix AI plc , a commercial-stage artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of…
News RenalytixaAI Appoints Thomas McLain as President and Chief Commercial Officer AIT News Desk Jul 30, 2019 Company Expands Leadership Team with Focus on Reimbursement for Artificial Intelligence Clinical in Vitro Diagnostic, KidneyinteIX Renalytix AI…
Machine Learning RenalytixAI Releases Positive Interim Results in Expanded Validation Study for KidneyIntelX AIT News Desk Jul 11, 2019 Data Development Plan Review Continues with FDA Under Breakthrough Device Designation Process; Performance Meets or Exceeds Targets for Identifying…
Technology RenalytixAI Initiates Clinical Validation Study of AI-Enabled KidneyinteIX for Diagnosing… AIT News Desk Jan 28, 2019 Validation Study to Assess Approximately 5,000 Patients with Participation from a Multi-Center Group of Leading U.S. Investigators Renalytix AI plc…